Retatrutide Side Effects by Dose: Nausea, Tingling, Heart Rate
Retatrutide side effects are mainly gastrointestinal and generally rise with the dose: across the phase 3 TRIUMPH trials, nausea affected 13.7 to 43.2 percent of participants versus 5.8 to 14.8 per...
Retatrutide Phase 3 Results: The Complete TRIUMPH Program Guide 2026
Eli Lilly's retatrutide (LY3437943) delivered 28.7% weight loss in its first Phase 3 readout. This 2026 guide breaks down every TRIUMPH trial, what the data means, and when FDA approval could land.
Retatrutide Dosage: Complete Guide for Beginners and Advanced Users
The complete retatrutide dosing guide, now updated with 2026 Phase 3 TRIUMPH-4 data: 28.7% mean weight loss at 12 mg over 68 weeks. Covers titration protocols, reconstitution calculator, the new 4 ...